Creo Medical Group (LON:CREO) Trading 0.2% Higher

Creo Medical Group PLC (LON:CREO)’s share price traded up 0.2% during trading on Thursday . The stock traded as high as GBX 147.95 ($1.93) and last traded at GBX 147.85 ($1.93), 14,895 shares were traded during mid-day trading. A decline of 7% from the average session volume of 16,051 shares. The stock had previously closed at GBX 147.50 ($1.93).

The firm has a market cap of $179.28 million and a price-to-earnings ratio of -13.53. The company has a 50-day moving average price of GBX 137.50 and a 200 day moving average price of GBX 178.44. The company has a quick ratio of 29.21, a current ratio of 29.58 and a debt-to-equity ratio of 6.17.

In other news, insider Charles Spicer acquired 14,220 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was acquired at an average cost of GBX 141 ($1.84) per share, for a total transaction of £20,050.20 ($26,199.14).

About Creo Medical Group (LON:CREO)

Creo Medical Limited develops and sells instruments for surgical endoscopy in the United Kingdom. The company is developing instruments for endoscopy through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. It offers Speedboat RS2 instrument for endoscopic submucosal dissection.

Recommended Story: Stock Symbol

Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.